1. Home
  2. NSPR vs CULP Comparison

NSPR vs CULP Comparison

Compare NSPR & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.72

Market Cap

43.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
CULP
Founded
2005
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
43.8M
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
NSPR
CULP
Price
$0.46
$3.72
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 108.5K
76.3K
Earning Date
11-03-2026
09-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.06
EPS
N/A
★ 0.47
Revenue
$2,310,000.00
★ $203,482,000.00
Revenue This Year
$9.14
$3.15
Revenue Next Year
$105.44
$1.77
P/E Ratio
★ N/A
$8.13
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$2.70
52 Week High
$2.41
$4.44

Technical Indicators

Market Signals
Indicator
NSPR
CULP
Relative Strength Index (RSI) 24.56 55.38
Support Level N/A $3.45
Resistance Level $1.00 $4.02
Average True Range (ATR) 0.08 0.20
MACD -0.01 0.00
Stochastic Oscillator 2.19 71.55

Price Performance

Historical Comparison
NSPR
CULP

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: